Mechanisms of Sex Disparities in Cardiovascular Function and Remodeling

Sarika Chaudhari, Spencer C. Cushen, Oluwatobiloba Osikoya, Paresh A. Jaini, Rachel Posey, Keisa Mathis, Styliani Goulopoulou

Research output: Contribution to journalReview article

Abstract

Epidemiological studies demonstrate disparities between men and women in cardiovascular disease prevalence, clinical symptoms, treatments, and outcomes. Enrollment of women in clinical trials is lower than men, and experimental studies investigating molecular mechanisms and efficacy of certain therapeutics in cardiovascular disease have been primarily conducted in male animals. These practices bias data interpretation and limit the implication of research findings in female clinical populations. This review will focus on the biological origins of sex differences in cardiovascular physiology, health, and disease, with an emphasis on the sex hormones, estrogen and testosterone. First, we will briefly discuss epidemiological evidence of sex disparities in cardiovascular disease prevalence and clinical manifestation. Second, we will describe studies suggesting sexual dimorphism in normal cardiovascular function from fetal life to older age. Third, we will summarize and critically discuss the current literature regarding the molecular mechanisms underlying the effects of estrogens and androgens on cardiac and vascular physiology and the contribution of these hormones to sex differences in cardiovascular disease. Fourth, we will present cardiovascular disease risk factors that are positively associated with the female sex, and thus, contributing to increased cardiovascular risk in women. We conclude that inclusion of both men and women in the investigation of the role of estrogens and androgens in cardiovascular physiology will advance our understanding of the mechanisms underlying sex differences in cardiovascular disease. In addition, investigating the role of sex-specific factors in the development of cardiovascular disease will reduce sex and gender disparities in the treatment and diagnosis of cardiovascular disease.

Original languageEnglish
Pages (from-to)375-411
Number of pages37
JournalComprehensive Physiology
Volume9
Issue number1
DOIs
StatePublished - 13 Dec 2018

Fingerprint

Cardiovascular Diseases
Sex Characteristics
Cardiovascular Physiological Phenomena
Estrogens
Androgens
Sex Factors
Gonadal Steroid Hormones
Blood Vessels
Testosterone
Epidemiologic Studies
Clinical Trials
Hormones
Health
Therapeutics
Research
Population

Cite this

Chaudhari, Sarika ; Cushen, Spencer C. ; Osikoya, Oluwatobiloba ; Jaini, Paresh A. ; Posey, Rachel ; Mathis, Keisa ; Goulopoulou, Styliani. / Mechanisms of Sex Disparities in Cardiovascular Function and Remodeling. In: Comprehensive Physiology. 2018 ; Vol. 9, No. 1. pp. 375-411.
@article{adc7b554920e498bb4bd79a8ce5ee4a9,
title = "Mechanisms of Sex Disparities in Cardiovascular Function and Remodeling",
abstract = "Epidemiological studies demonstrate disparities between men and women in cardiovascular disease prevalence, clinical symptoms, treatments, and outcomes. Enrollment of women in clinical trials is lower than men, and experimental studies investigating molecular mechanisms and efficacy of certain therapeutics in cardiovascular disease have been primarily conducted in male animals. These practices bias data interpretation and limit the implication of research findings in female clinical populations. This review will focus on the biological origins of sex differences in cardiovascular physiology, health, and disease, with an emphasis on the sex hormones, estrogen and testosterone. First, we will briefly discuss epidemiological evidence of sex disparities in cardiovascular disease prevalence and clinical manifestation. Second, we will describe studies suggesting sexual dimorphism in normal cardiovascular function from fetal life to older age. Third, we will summarize and critically discuss the current literature regarding the molecular mechanisms underlying the effects of estrogens and androgens on cardiac and vascular physiology and the contribution of these hormones to sex differences in cardiovascular disease. Fourth, we will present cardiovascular disease risk factors that are positively associated with the female sex, and thus, contributing to increased cardiovascular risk in women. We conclude that inclusion of both men and women in the investigation of the role of estrogens and androgens in cardiovascular physiology will advance our understanding of the mechanisms underlying sex differences in cardiovascular disease. In addition, investigating the role of sex-specific factors in the development of cardiovascular disease will reduce sex and gender disparities in the treatment and diagnosis of cardiovascular disease.",
author = "Sarika Chaudhari and Cushen, {Spencer C.} and Oluwatobiloba Osikoya and Jaini, {Paresh A.} and Rachel Posey and Keisa Mathis and Styliani Goulopoulou",
year = "2018",
month = "12",
day = "13",
doi = "10.1002/cphy.c180003",
language = "English",
volume = "9",
pages = "375--411",
journal = "Comprehensive Physiology",
issn = "2040-4603",
publisher = "Wiley-Blackwell",
number = "1",

}

Mechanisms of Sex Disparities in Cardiovascular Function and Remodeling. / Chaudhari, Sarika; Cushen, Spencer C.; Osikoya, Oluwatobiloba; Jaini, Paresh A.; Posey, Rachel; Mathis, Keisa; Goulopoulou, Styliani.

In: Comprehensive Physiology, Vol. 9, No. 1, 13.12.2018, p. 375-411.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Mechanisms of Sex Disparities in Cardiovascular Function and Remodeling

AU - Chaudhari, Sarika

AU - Cushen, Spencer C.

AU - Osikoya, Oluwatobiloba

AU - Jaini, Paresh A.

AU - Posey, Rachel

AU - Mathis, Keisa

AU - Goulopoulou, Styliani

PY - 2018/12/13

Y1 - 2018/12/13

N2 - Epidemiological studies demonstrate disparities between men and women in cardiovascular disease prevalence, clinical symptoms, treatments, and outcomes. Enrollment of women in clinical trials is lower than men, and experimental studies investigating molecular mechanisms and efficacy of certain therapeutics in cardiovascular disease have been primarily conducted in male animals. These practices bias data interpretation and limit the implication of research findings in female clinical populations. This review will focus on the biological origins of sex differences in cardiovascular physiology, health, and disease, with an emphasis on the sex hormones, estrogen and testosterone. First, we will briefly discuss epidemiological evidence of sex disparities in cardiovascular disease prevalence and clinical manifestation. Second, we will describe studies suggesting sexual dimorphism in normal cardiovascular function from fetal life to older age. Third, we will summarize and critically discuss the current literature regarding the molecular mechanisms underlying the effects of estrogens and androgens on cardiac and vascular physiology and the contribution of these hormones to sex differences in cardiovascular disease. Fourth, we will present cardiovascular disease risk factors that are positively associated with the female sex, and thus, contributing to increased cardiovascular risk in women. We conclude that inclusion of both men and women in the investigation of the role of estrogens and androgens in cardiovascular physiology will advance our understanding of the mechanisms underlying sex differences in cardiovascular disease. In addition, investigating the role of sex-specific factors in the development of cardiovascular disease will reduce sex and gender disparities in the treatment and diagnosis of cardiovascular disease.

AB - Epidemiological studies demonstrate disparities between men and women in cardiovascular disease prevalence, clinical symptoms, treatments, and outcomes. Enrollment of women in clinical trials is lower than men, and experimental studies investigating molecular mechanisms and efficacy of certain therapeutics in cardiovascular disease have been primarily conducted in male animals. These practices bias data interpretation and limit the implication of research findings in female clinical populations. This review will focus on the biological origins of sex differences in cardiovascular physiology, health, and disease, with an emphasis on the sex hormones, estrogen and testosterone. First, we will briefly discuss epidemiological evidence of sex disparities in cardiovascular disease prevalence and clinical manifestation. Second, we will describe studies suggesting sexual dimorphism in normal cardiovascular function from fetal life to older age. Third, we will summarize and critically discuss the current literature regarding the molecular mechanisms underlying the effects of estrogens and androgens on cardiac and vascular physiology and the contribution of these hormones to sex differences in cardiovascular disease. Fourth, we will present cardiovascular disease risk factors that are positively associated with the female sex, and thus, contributing to increased cardiovascular risk in women. We conclude that inclusion of both men and women in the investigation of the role of estrogens and androgens in cardiovascular physiology will advance our understanding of the mechanisms underlying sex differences in cardiovascular disease. In addition, investigating the role of sex-specific factors in the development of cardiovascular disease will reduce sex and gender disparities in the treatment and diagnosis of cardiovascular disease.

UR - http://www.scopus.com/inward/record.url?scp=85058750929&partnerID=8YFLogxK

U2 - 10.1002/cphy.c180003

DO - 10.1002/cphy.c180003

M3 - Review article

C2 - 30549017

AN - SCOPUS:85058750929

VL - 9

SP - 375

EP - 411

JO - Comprehensive Physiology

JF - Comprehensive Physiology

SN - 2040-4603

IS - 1

ER -